Login
$PCVX
$59.97 -$0.46 (0.76%) Close

Ownership

13F as of Q2 2026 · 148.8M shares outstanding

Who owns PCVX?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 68.5%
FMR LLC 14.0% · Jupiter Topco LLC 12.1%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
329
-7 vs last qtr
Net shares bought
+4.5M
by institutions in Q2 2026
New / sold out
48 / 55
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +18.0M
  • FMR LLC +4.4M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −16.6M
  • Paradigm Biocapital Advisors LP −2.7M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$12.4M
24 notices from 7 people
Shares covered
206.7K
0.14% of the company
Arranged in advance
92%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$1.7M$3.3MNovDec 2025: $1.0M without a planDecJanFebMar 2026: $684.7K under a 10b5-1 planMarApr 2026: $310.7K under a 10b5-1 planAprMay 2026: $128.8K under a 10b5-1 planMayJun 2026: $3.2M under a 10b5-1 planJunJul 2026: $1.7M under a 10b5-1 planJulAug 2026: $1.6M under a 10b5-1 planAugSep 2026: $372.1K under a 10b5-1 planSepOct 2026: $3.3M under a 10b5-1 planOct
Largest proposed sellers
  • Pickering Grant Officer 10b5-1 $3.58M
  • Wassil Jim Officer 10b5-1 $3.12M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+360.6%
+35.73% a year
Each share's claim on the business
−78.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $312M
over 6 fiscal years
Diluted shares, split-adjusted
28.7M83.1M137.5M2020: 29.5M shares'202021: 51.9M shares'212022: 64.9M shares'222023: 97.2M shares'232024: 122.0M shares'242025: 136.1M shares'25
Buybacks Stock-based comp
$0$69.4M$138.8M2020 buybacks: $02020 stock comp: $5.4M'202021 buybacks: $02021 stock comp: $10.7M'212022 buybacks: $02022 stock comp: $23.7M'222023 buybacks: $02023 stock comp: $48.8M'232024 buybacks: $02024 stock comp: $84.8M'242025 buybacks: $02025 stock comp: $138.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years54% 3–5 years15% 1–3 years13% Under 1 year18%
Quarterly turnover
22.0%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting PCVX on Form 13F
F
FMR LLC
Shares
20.9M
% of company
14.01%
Change vs last qtr
+4.4M (+26.4%)
Held since
≤2021
JT
Jupiter Topco LLC
Shares
18.0M
% of company
12.07%
Change vs last qtr
NEW
Held since
Q2 '26

28 more super investors behind a free account

See every manager holding Vaxcyte Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PCVX on Form N-PORT; together they hold 53.6% of the company
VT
Position value
$267M
% of company
3.08%
% of the fund
0.01%
As of
June 30, 2026
TR
T. Rowe Price Capital Appreciation Fund, Inc.
Position value
$233M
% of company
2.69%
% of the fund
0.33%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Vaxcyte Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
PG
Pickering Grant
Insider
Shares
908.8K
% of company
0.61%
Change vs last qtr
—
Held since
—
GA
Guggenhime Andrew
Insider
Shares
157.2K
% of company
0.11%
Change vs last qtr
—
Held since
—

14 more holders behind a free account

See every insider and 5%+ holder of Vaxcyte Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support